Access cutting-edge diabetic macular edema treatment through this clinical trial at a research site in Mountain View. Study-provided care at no cost to qualified participants.
Access diabetic macular edema specialists in Mountain View at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diabetic macular edema treatment provided free
EYE-RES-103 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of EYE103 in comparison with the active control, ranibizumab, in patients with diabetic macular edema (DME). In the first year, all 3 treatment groups will be treated every 4 weeks with either EYE103 or ranibizumab. Beginning at Year 2, the frequency of treatment for participants will shift based on a personalized treatment interval algorithm. Approximately 960 participants will be ent
Sponsor: EyeBiotech Ltd.
Check if you qualify for this diabetic macular edema clinical trial in Mountain View, CA
If you're searching for diabetic macular edema treatment options in Mountain View, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Mountain View research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetic macular edema specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.